First Approved Treatment?, 'Shark Tank' for Testing & Virus-Sniffing Dogs (+ Virologist Q&A)- Thursday, April 30th, 2020
The NewsWorthy
Erica Mandy
4.7 • 1.3K Ratings
🗓️ 30 April 2020
⏱️ 15 minutes
🧾️ Download transcript
Summary
The news to know for Thursday, April 30th, 2020!
What to know today about the first drug that could get federal approval as a COVID-19 treatment, how the government is hoping to find solutions with a Shark Tank-like program, and the way dogs are working to sniff out the disease.
Plus, whose salary will go from $40 million to zero, a new record for social media and when to catch a Parks and Rec comeback.
Those stories and more in less than 10 minutes!
Then, hang out after the news for the Thing to Know Thursday bonus interview, where a virologist answers unique questions about COVID-19.
Head to www.theNewsWorthy.com/shownotes to read more about any of the stories mentioned in this episode or see the sources below.
This episode is brought to you by www.FunctionofBeauty.com/newsworthy.
Thanks to The NewsWorthy Insiders! Become one here: www.theNewsWorthy.com/insider
Sources:
Death Toll, Case Count: Johns Hopkins
Trump Not Extending Social Distancing Guidelines: AP, Politico
Second Wave "Inevitable": CNN, The Hill, LA Times
Remdesivir Trial Positive Results: Stat, NIH, NBC News, NYT
"Shark Tank" for Testing: Stat, Axios
GDP First-Quarter Decline: WSJ, NPR
Fed Holds Rate Near Zero: USA Today, AP
Andrew Yang Sues New York: Politico, CBS News
Training Dogs to Smell Coronavirus: WaPo, Philadelphia Inquirer
TikTok Tops Two Billion Downloads: TechCrunch, The Verge
Facebook Sees Surge in Usage: Engadget, Facebook
Microsoft Teams Jumps 70 Percent: The Verge, VentureBeat
Uber/Lyft Layoffs: Mashable, The Information, CNBC
Aerospace Layoffs: WSJ, NY Times
NFL Commissioner Taking $0 Salary: USA Today, AP
Amazon to Stream TNF: TechCrunch, The Verge, ABC News
Parks & Rec Charity Episode: CNN, Rolling Stone
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Today is Thursday, April 30th. |
| 0:02.0 | What to know today about the first drug that could get federal approval |
| 0:05.0 | as a COVID-19 treatment, |
| 0:06.7 | how the government is hoping to find solutions with a shark tank-like program |
| 0:10.4 | and the way dogs are working to sniff out the disease. |
| 0:13.0 | Plus, whose salary will go from 40 million to zero. |
| 0:16.0 | There's a new record for social media |
| 0:18.0 | and when to catch a Parks and Rec comeback. |
| 0:20.0 | Then hang out after the news for Thing to note Thursday's bonus interview where a |
| 0:23.5 | virologist answers unique questions about COVID-19. |
| 0:27.0 | Welcome, welcome to the newsworthy. |
| 0:31.2 | All the days news in less than 10 minutes fast fair fun and on the go I'm Erica |
| 0:36.7 | Mandy thanks so much for being here you ready let's do this |
| 0:44.4 | the federal social distancing guidelines expire today and President Trump does not plan to renew |
| 0:49.0 | them. |
| 0:50.0 | To be clear, this doesn't actually mean much since they were only recommendations to begin with, not requirements. |
| 0:54.8 | But it signals a change in the message from the White House from |
| 0:58.0 | Stay at Home to reopen with caution. |
| 1:00.8 | The President himself has been cooped up in the White House for more than a month. |
| 1:04.0 | Now he plans to resume out-of-state travel. He's starting with a trip to Arizona next week and says he's also |
| 1:09.1 | considering making a trip to Ohio. Meanwhile, the U.S. death toll is still rising often by 1500 to 2,000 a day. |
| 1:16.0 | As of early this morning about 61,000 people have died from COVID-19 in the US. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Erica Mandy, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Erica Mandy and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.